-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Es/B0l/gB78OkH6TGd7rHDiEYTXKRNNHVacQXkgYGj3uxXg58LsRsHDIF6v1As+L 62BL2kPuNOeaN/k44x5mDA== 0001144204-10-014955.txt : 20100322 0001144204-10-014955.hdr.sgml : 20100322 20100322164858 ACCESSION NUMBER: 0001144204-10-014955 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100322 DATE AS OF CHANGE: 20100322 GROUP MEMBERS: KENNETH M. GARSCHINA GROUP MEMBERS: MICHAEL E. MARTINO FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MASON CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001218735 IRS NUMBER: 134121993 FILING VALUES: FORM TYPE: SC 13G SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-37954 FILM NUMBER: 10696965 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 SC 13G 1 v178194_sc13g.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934* OSI Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.01 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 671040103 - -------------------------------------------------------------------------------- (CUSIP Number) March 19, 2010 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) - --------------------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 12 Pages - ---------------------------- CUSIP No. 671040103 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Mason Capital Management LLC, in its capacity as investment manager for certain investment funds and managed accounts - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 2,948,591 OWNED BY ----------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON WITH -0- ----------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 2,948,591 ----------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,948,591 Shares of Common Stock - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES [_] CERTAIN SHARES (See Instructions) - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) OO - -------------------------------------------------------------------------------- Page 2 of 12 Pages - ---------------------------- CUSIP No. 671040103 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Kenneth M. Garschina - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY ----------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON WITH 2,948,591 ----------------------------------------------------------- 7 SOLE DISPOSITIVE POWER -0- ----------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 2,948,591 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,948,591 Shares of Common Stock - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES [_] CERTAIN SHARES (See Instructions) - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- Page 3 of 12 Pages - ---------------------------- CUSIP No. 671040103 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS Michael E. Martino - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY ----------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON WITH 2,948,591 ----------------------------------------------------------- 7 SOLE DISPOSITIVE POWER -0- ----------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 2,948,591 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,948,591 Shares of Common Stock - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES [_] CERTAIN SHARES (See Instructions) - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- Page 4 of 12 Pages SCHEDULE 13G ITEM 1(a). NAME OF ISSUER: --------------- OSI Pharmaceuticals, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: ------------------------------------------------ 41 Pinelawn Road Melville, NY 11747 ITEM 2(a). NAME OF PERSON FILING: ---------------------- This Schedule is being filed jointly by the following reporting persons (hereinafter sometimes collectively referred to as the "Reporting Persons") pursuant to an Agreement of Joint Filing attached hereto as Exhibit A: (i) Mason Capital Management LLC, a Delaware limited liability company ("Mason Management"); (ii) Kenneth M. Garschina; and (iii) Michael E. Martino. Mason Management, Mr. Garschina and Mr. Martino are filing this Schedule with respect to 2,948,591 shares of Common Stock (the "Shares of Common Stock") directly owned by Mason Capital L.P., a Delaware limited partnership ("Mason Capital LP"), Mason Capital Master Fund, L.P., a Cayman Islands exempted limited partnership ("Mason Capital Master Fund"), and certain other funds and accounts (the "Managed Accounts"). Mason Management is the investment manager of each of Mason Capital LP, Mason Capital Master Fund and the Managed Accounts, and Mason Management may be deemed to have beneficial ownership over the Shares of Common Stock reported in this Schedule by virtue of the authority granted to Mason Management by Mason Capital LP, Mason Capital Master Fund and the Managed Accounts to vote and dispose of such shares. Mr. Garschina and Mr. Martino are managing principals of Mason Management. ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: ------------------------------------------------------------ The principal business office address of Mason Management, Mr. Garschina and Mr. Martino is: 110 East 59th Street New York, New York 10022 ITEM 2(c). CITIZENSHIP: ------------ Page 5 of 12 Pages The place of organization or citizenship of each Reporting Person is as follows: Name of Reporting Person Place of Organization/Citizenship - ------------------------ --------------------------------- Mason Capital Management LLC Delaware Kenneth M. Garschina United States Michael E. Martino United States ITEM 2(d). TITLE OF CLASS OF SECURITIES: ---------------------------- Common Stock, par value $.01 per share ITEM 2(e). CUSIP NUMBER: ------------ 671040103 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO ss.ss. 240.13d-1(b), OR -------------------------------------------------------------- 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: -------------------------------------------------------------- Not applicable. ITEM 4. OWNERSHIP. --------- Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (i) Mason Capital Management LLC (a) Amount beneficially owned: 2,948,591. (b) Percent of class: 5.1%. (c) Number of shares as to which the person has: (i) Sole power to vote or direct the vote 2,948,591. (ii) Shared power to vote or direct the vote -0-. (iii) Sole power to dispose or direct the disposition of 2,948,591. (iv) Shared power to dispose or direct the disposition of -0-. (ii) Kenneth M. Garschina Page 6 of 12 Pages (a) Amount beneficially owned: 2,948,591. (b) Percent of class: 5.1%. (c) Number of shares as to which the person has: (i) Sole power to vote or direct the vote -0-. (ii) Shared power to vote or direct the vote 2,948,591. (iii) Sole power to dispose or direct the disposition of -0-. (iv) Shared power to dispose or direct the disposition of 2,948,591. (iii) Michael E. Martino (a) Amount beneficially owned: 2,948,591. (b) Percent of class: 5.1%. (c) Number of shares as to which the person has: (i) Sole power to vote or direct the vote -0-. (ii) Shared power to vote or direct the vote 2,948,591. (iii) Sole power to dispose or direct the disposition of -0-. (iv) Shared power to dispose or direct the disposition of 2,948,591. The number of shares beneficially owned and the percentage of outstanding shares represented thereby for each Reporting Person have been computed in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. The percentages of ownership described above are based on 58,309,364 Shares of Common Stock outstanding as of February 15, 2010, as reported in the issuer's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 24, 2010. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. -------------------------------------------- If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Page 7 of 12 Pages ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. --------------------------------------------------------------- The right to receive dividends from, or the proceeds from the sale of, all Shares of Common Stock reported in this Schedule as beneficially owned by Mason Management, Mr. Garschina and Mr. Martino is held by Mason Capital LP, Mason Capital Master Fund or the Managed Accounts, as the case may be, all of which are the advisory clients of Mason Management. To the knowledge of the Reporting Persons, none of these advisory clients holds such right with respect to more than five percent of the outstanding shares of Common Stock. Mason Management, Mr. Garschina and Mr. Martino disclaim beneficial ownership of all Shares of Common Stock reported in this Schedule pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH --------------------------------------------------------- ACQUIRED THE SECURITIES BEING REPORTED ON BY THE PARENT -------------------------------------------------------- HOLDING COMPANY OR CONTROL PERSON. ---------------------------------- Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. --------------------------------------------------------- Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. ------------------------------ Not applicable. Page 8 of 12 Pages ITEM 10. CERTIFICATION. ------------- By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE --------- After reasonable inquiry and to the best of the knowledge and belief of the undersigned Reporting Person, the undersigned Reporting Person certifies that the information set forth in this statement with respect to it is true, complete and correct. Dated: March 22, 2010 MASON CAPITAL MANAGEMENT LLC By: /s/ John Grizzetti ---------------------------- John Grizzetti Chief Financial Officer Page 9 of 12 Pages ITEM 10. CERTIFICATION. ------------- By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE --------- After reasonable inquiry and to the best of the knowledge and belief of the undersigned Reporting Person, the undersigned Reporting Person certifies that the information set forth in this statement with respect to him is true, complete and correct. Dated: March 22, 2010 /s/ Kenneth M. Garschina ---------------------------- Kenneth M. Garschina Page 10 of 12 Pages ITEM 10. CERTIFICATION. ------------- By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE --------- After reasonable inquiry and to the best of the knowledge and belief of the undersigned Reporting Person, the undersigned Reporting Person certifies that the information set forth in this statement with respect to him is true, complete and correct. Dated: March 22, 2010 /s/ Michael E. Martino ---------------------------- Michael E. Martino Page 11 of 12 Pages EXHIBIT A AGREEMENT OF JOINT FILING OSI PHARMACEUTICALS, INC. COMMON STOCK In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of a Statement on Schedule 13G and any and all amendments thereto, with respect to the above referenced securities and that this Agreement be included as an Exhibit to such filing. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement. IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of this 22nd day of March, 2010. MASON CAPITAL MANAGEMENT LLC By: /s/ John Grizzetti ---------------------------- John Grizzetti Chief Financial Officer /s/ Kenneth M. Garschina ---------------------------- Kenneth M. Garschina /s/ Michael E. Martino ---------------------------- Michael E. Martino Page 12 of 12 Pages -----END PRIVACY-ENHANCED MESSAGE-----